SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31

Savara Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$4.63+0.18 (+4.04%)

Close on Oct 19, 2026

Market cap: $1.17B
P/E (TTM): –
Dividend yield: –

Savara Inc cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Depreciation & Amortization	0.03	0.02	-0.01	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.04	0.05	0.05	0.07	0.06	0.07	0.06	0.06	0.06	0.06	0.31	0.14	0.13	0.15	0.11	–	–	–	0.01	0.01	0.02
Stock-Based Compensation	7.77	11	5.36	3.43	2.67	2.97	3.04	2.37	2.20	2.26	1.36	1.00	0.96	0.86	0.56	0.45	0.46	0.57	0.85	0.69	0.77	0.95	0.81	1.93	1.18	1.93	1.15	1.15	1.15	1.00	0.95	1.99	0.39	0.41	0.20	0.11	0.16	0.08	0.06	0.04
Deferred Income Taxes	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-2.50	0	0	-4.56	–	–	–	–	–	–
Change in Accounts Payable	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.84	0.11	-0.55	0.02	-1.70	0.53	1.32	1.01	0.53
Operating Cash Flow	-30	-33	-25	-23	-26	-27	-23	-23	-22	-21	-16	-13	-10	-12	-8.65	-8.16	-9.32	-8.43	-9.36	-8.93	-12	-9.60	-12	-6.71	-7.75	-13	-9.95	-11	-13	-11	-10	-8.76	-10	-9.67	-9.47	-8.25	-7.67	-2.84	-2.19	-2.87
Capital Expenditures	-0.22	-0.05	0.00	0.00	-0.02	0.00	0.01	0.00	-0.02	-0.01	-0.02	-0.04	-0.23	0.00	0	0.00	–	–	-0.04	-0.01	–	–	-0.01	-0.02	-0.02	0.00	-0.01	-0.01	-0.04	-0.10	-0.06	-0.02	-0.05	-0.02	-0.43	0.00	0.00	-0.06	0	0.00
Purchase of Investments	–	–	-127	-23	-40	-15	-32	-139	-3.44	-31	-39	-95	-31	-30	-73	0	0	-16	-23	-24	-20	-94	-16	-35	0	-36	–	–	–	-46	-34	-63	-8.83	-16	-43	–	–	–	–	–
Sale & Maturity of Investments	52	39	29	44	64	44	50	41	33	42	45	38	30	24	14	33	25	70	21	35	17	17	16	28	18	37	36	19	31	53	35	28	14	25	–	–	–	–	–	–
Investing Cash Flow	33	39	-94	21	24	29	18	-98	30	11	6.57	-57	-1.01	-6.10	-59	33	25	54	-1.27	13	-3.43	-78	-0.38	-6.86	18	-1.79	17	6.59	-15	7.32	0.87	-36	12	9.39	-39	-33	3.44	-0.06	0	0.00
Stock Issued	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	–	–	0.00	5.66	19	4.89	0.01	0	0	0.49	0.68	0.89	–	–	2.02	3.91
Debt Issued	–	–	0	0	0	30	–	–	–	–	–	–	–	–	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Debt Repaid	–	–	0	0.00	0	-27	–	–	–	–	–	–	–	–	0	0	–	–	–	–	–	–	0	0	0	-0.51	–	–	–	–	–	–	–	–	0	0	–	–	–	–
Financing Cash Flow	0.19	-0.20	136	-0.02	-0.05	2.32	-0.84	118	0.06	0.05	7.90	75	0.10	0.03	0.00	0.00	0.09	0.00	0.01	0.01	0.32	120	0	1.83	2.33	-0.47	25	5.71	19	4.90	9.10	46	0.02	0.27	51	0.44	55	-0.42	0.10	4.32
Foreign Exchange Rate Adjustments	-0.03	0.07	-0.04	-0.07	-0.14	-0.03	-0.07	0.08	-0.02	0.00	0.03	-0.06	-0.07	-0.02	0.12	-0.15	-0.04	-0.02	-0.06	-0.02	-0.03	-0.03	0.34	-0.16	-0.05	0.04	-0.03	0.07	-0.07	0.01	-0.12	0.01	-0.02	0.01	0.08	–	–	–	–	–
Net Change in Cash	3.01	5.61	17	-1.16	-2.12	4.43	-6.30	-2.44	7.08	-9.80	-1.11	4.95	-11	-18	-68	25	16	45	-11	4.05	-15	33	-12	-12	13	-15	32	0.96	-8.84	1.37	-0.65	1.34	1.48	0.00	2.31	-41	51	-2.91	-2.14	1.45
Free Cash Flow	-30	-33	-25	-23	-26	-27	-23	-23	-23	-21	-16	-13	-10	-12	-8.65	-8.17	–	–	-9.40	-8.94	–	–	-12	-6.72	-7.77	-13	-9.96	-11	-13	-11	-11	-8.78	-10	-9.69	-9.90	-8.25	-7.67	-2.90	-2.19	-2.87
Interest Paid	0.63	0.62	0.66	0.72	0.50	1.33	0.51	0.54	0.54	0.54	0.54	0.53	0.51	0.46	0.43	0.33	0.37	0.48	0.50	0.50	0.49	0.48	–	–	–	–	0.50	0.54	0.53	0.53	0.37	0.35	0.35	0.33	0.37	0.26	0.03	0.08	0.17	0.34

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -63.5%

Financial strength

Current ratio: 10.13
Debt to equity: 0.21
Debt to assets: 15.7%
Cash to current liabilities: 237.5%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 8.17
Dividend yield: –